Ozempic (drogas GPL-1) vs. modulação acústica. Você escolhe. ~~ A modulação acústica das células adiposas, conforme descrito no estudo da Universidade de Kyoto de 2025, e o Ozempic (semaglutida), um agonista do receptor GLP-1, visam tratar a obesidade, mas diferem significativamente no mecanismo, aplicação e estágio de desenvolvimento. A abordagem de ondas sonoras suprime de forma não invasiva a diferenciação de adipócitos em até 15% in vitro por meio de mecanotransdução e vias mediadas por Ptgs2, oferecendo uma terapia potencialmente livre de drogas e efeitos colaterais mínimos, embora permaneça em pesquisas iniciais com eficácia in vivo não comprovada. Em contraste, o Ozempic, um medicamento injetável aprovado pela FDA, promove a perda de peso imitando o GLP-1, reduzindo o apetite e retardando o esvaziamento gástrico, alcançando uma redução de 15 a 20% do peso corporal em ensaios clínicos. No entanto, traz riscos como náusea, pancreatite e dependência de longo prazo. Embora o Ozempic seja um tratamento sistêmico comprovado, a terapia acústica não é invasiva e corresponde ao impacto do Ozempic.
Sonic BOOM!! Soundwaves help you lose weight with no injections no drugs! ~~ A groundbreaking study published in Communications Biology on April 19, 2025, by researchers at Kyoto University, led by Masahiro Kumeta, has revealed that audible sound waves can influence cellular behavior, specifically suppressing fat cell (adipocyte) differentiation by modulating gene expression. Titled “Acoustic modulation of mechanosensitive genes and adipocyte differentiation,” the study demonstrates how sound, as a non-invasive mechanical stimulus, can alter cellular processes, opening potential avenues for applications in biotechnology and obesity management. Background and Motivation Cells are known to respond to mechanical stimuli through mechanotransduction, a process where physical forces are converted into biochemical signals. While previous research has explored high-intensity ultrasound or low-vibration stimuli, the effects of audible sound waves (20 Hz to 20 kHz, within the human hearing range) on cellular behavior have been underexplored due to challenges in isolating sound’s effects from confounding factors like heat or vibrations. Kumeta’s team built on their 2018 findings, which showed audible sound could modulate mechanosensitive genes, but sought to refine the experimental setup to directly attribute changes to acoustic waves and investigate their impact on fat cell development. The researchers designed a precise sound emission system to deliver controlled acoustic waves to cultured cells, minimizing extraneous effects. The setup involved: •Vibration Transducer: A digital audio player connected to an amplifier sent sound signals to an upside-down vibration transducer mounted on a shelf. This transducer transmitted acoustic waves through a diaphragm to a cell culture dish, simulating physiological sound levels (approximately 100 Pa, comparable to loud conversational or musical sound). •Sound Patterns: Three sound types were tested: a 440 Hz sine wave (equivalent to the musical note A), a 14 kHz high-frequency tone, and white noise (random broadband sound). These were applied continuously for 2 or 24 hours or in specific schedules for differentiation experiments. •Cell Types: The study primarily used murine C2C12 myoblasts (muscle precursor cells) for gene expression analysis and 3T3-L1 preadipocytes (fat cell precursors) for adipocyte differentiation studies. •Analysis Techniques: RNA sequencing identified differentially expressed genes, while microscopy and biochemical assays assessed cellular morphology, differentiation, and molecular pathways. Specific focus was placed on the gene Ptgs2 (prostaglandin-endoperoxide synthase 2, also known as Cox-2) due to its robust response to sound. The experiments were conducted with controls to ensure sound-specific effects, such as maintaining consistent temperature and minimizing vibrational artifacts. For adipocyte differentiation, 3T3-L1 cells were exposed to sound during the initial three-day induction phase with a differentiation medium containing methylisobutylxanthine, dexamethasone, and insulin (MDI), followed by four days in insulin-only medium. The findings have profound implications for both fundamental biology and clinical applications: •Non-Invasive Therapies: Since sound is non-material, acoustic stimulation offers a safe, immediate, and non-invasive method to modulate cellular behavior. The study suggests potential for sound-based therapies to manage obesity by inhibiting fat cell formation without drugs or surgery. •Medical Applications: Beyond obesity, acoustic modulation could guide stem cell differentiation, promote tissue healing, or regulate inflammation, given Ptgs2’s role in these processes. The non-invasive nature of sound makes it appealing for clinical settings, potentially delivered via wearable devices. Link:
Mostrar original
64,67 mil
165
O conteúdo desta página é fornecido por terceiros. A menos que especificado de outra forma, a OKX não é a autora dos artigos mencionados e não reivindica direitos autorais sobre os materiais apresentados. O conteúdo tem um propósito meramente informativo e não representa as opiniões da OKX. Ele não deve ser interpretado como um endosso ou aconselhamento de investimento de qualquer tipo, nem como uma recomendação para compra ou venda de ativos digitais. Quando a IA generativa é utilizada para criar resumos ou outras informações, o conteúdo gerado pode apresentar imprecisões ou incoerências. Leia o artigo vinculado para mais detalhes e informações. A OKX não se responsabiliza pelo conteúdo hospedado em sites de terceiros. Possuir ativos digitais, como stablecoins e NFTs, envolve um risco elevado e pode apresentar flutuações significativas. Você deve ponderar com cuidado se negociar ou manter ativos digitais é adequado para sua condição financeira.